全文获取类型
收费全文 | 1648篇 |
免费 | 153篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 94篇 |
妇产科学 | 29篇 |
基础医学 | 215篇 |
口腔科学 | 17篇 |
临床医学 | 226篇 |
内科学 | 254篇 |
皮肤病学 | 17篇 |
神经病学 | 135篇 |
特种医学 | 163篇 |
外科学 | 185篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 176篇 |
眼科学 | 22篇 |
药学 | 118篇 |
中国医学 | 2篇 |
肿瘤学 | 117篇 |
出版年
2024年 | 1篇 |
2023年 | 18篇 |
2022年 | 19篇 |
2021年 | 54篇 |
2020年 | 40篇 |
2019年 | 47篇 |
2018年 | 58篇 |
2017年 | 39篇 |
2016年 | 46篇 |
2015年 | 64篇 |
2014年 | 78篇 |
2013年 | 68篇 |
2012年 | 108篇 |
2011年 | 113篇 |
2010年 | 63篇 |
2009年 | 58篇 |
2008年 | 65篇 |
2007年 | 80篇 |
2006年 | 67篇 |
2005年 | 63篇 |
2004年 | 59篇 |
2003年 | 49篇 |
2002年 | 50篇 |
2001年 | 5篇 |
2000年 | 10篇 |
1999年 | 12篇 |
1998年 | 45篇 |
1997年 | 63篇 |
1996年 | 52篇 |
1995年 | 36篇 |
1994年 | 40篇 |
1993年 | 29篇 |
1992年 | 16篇 |
1991年 | 15篇 |
1990年 | 4篇 |
1989年 | 22篇 |
1988年 | 26篇 |
1987年 | 19篇 |
1986年 | 19篇 |
1985年 | 20篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 14篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 4篇 |
1975年 | 5篇 |
排序方式: 共有1811条查询结果,搜索用时 31 毫秒
81.
Shana Castillo Kimberley Begley Eric Hoie Gary Elsasser Sam Augustine 《American journal of pharmaceutical education》2014,78(2)
Objective. To teach drug utilization review (DUR) skills to pharmacy students and assess their abilities and confidence before and after training.Design. Profile reviews and online and live drug-utilization-review activities of increasing difficulty were incorporated into the first (P1), second (P2), and third (P3) years of the Pharmacy Skills Training Laboratory sequence in a doctor of pharmacy (PharmD) curriculum.Assessment. An online survey instrument was administered to gauge how comfortable students were with specific DUR skills before and after the activities. Students’ confidence in performing specific DUR skills improved after completing the activities.Conclusion. Profile reviews, as well as online and live medication reviews, gave students numerous opportunities to practice drug utilization review skills throughout the first 3 years of the pharmacy curriculum. Students’ confidence in performing specific drug utilization review skills improved after the activities. Students’ ability to perform the skills also improved as measured with the developed checklist in section V and VI of the Pharmacy Skills Laboratory sequence. 相似文献
82.
The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis
Bosch Lena de Haan Judith J. Bastemeijer Marissa van der Burg Jennifer van der Worp Erik Wesseling Marian Viola Margarida Odille Clémene el Azzouzi Hamid Pasterkamp Gerard Sluijter Joost P.G. Wever Kimberley E. de Jager Saskia C.A. 《Heart failure reviews》2021,26(6):1515-1524
Heart Failure Reviews - The transverse aortic constriction (TAC) model is frequently used to study adverse cardiac remodeling upon pressure overload. We set out to define the most important... 相似文献
83.
Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells 总被引:2,自引:1,他引:2
Using two different approaches, we have investigated the types of G proteins coupled to CC chemokine receptors. First, permeabilization of interleukin-2-activated natural killer (IANK) cells with streptolysin-O and introduction of anti-G protein antibodies inside these cells resulted in the following. (1) Anti-G(s), anti-G(o), and anti-G(z) inhibited the migration of IANK cells in response to macrophage- inflammatory protein-1 alpha (MIP-1 alpha), monocyte chemoattractant protein-1 (MCP-1), or regulated on activation normal T cell expressed and secreted (RANTES). (2) Anti-Gi inhibited their migration in response to MCP-1 or RANTES but not in response to MIP-1 alpha. Second, incubation of IANK cell membranes with anti-G protein antibodies before incubating with (gamma-35S) GTP or (gamma-32P) GTP, resulted in the following. (1) Anti-G(s), anti-G(o), or anti-G(z) inhibited GTP binding and GTPase activity in the presence of MIP-1 alpha, or RANTES. (2) Anti- G(i) inhibited GTP binding and GTPase activity in the presence of MCP-1 or RANTES but not in the presence of MIP-1 alpha. The inhibitory effect of anti-G protein antibodies was reversed upon incubating these antibodies with their respective synthetic peptides before addition to IANK cell membranes. These results suggest that MCP-1 and RANTES receptors are promiscuously coupled to multiple G proteins in IANK cell membranes and that this coupling is different from MIP-1 alpha receptors, which seem to be coupled to G(s), G(o), and G(z) but not to G(i). 相似文献
84.
Crist WM; Shuster JJ; Falletta J; Pullen DJ; Berard CW; Vietti TJ; Alvarado CS; Roper MA; Prasthofer E; Grossi CE 《Blood》1988,72(6):1891-1897
The immunophenotypes of lymphoblasts from children with newly diagnosed T-cell acute lymphoid leukemia (T-ALL, n = 101) or T-cell non-Hodgkin lymphoma (T-NHL, n = 31) were analyzed to correlate stage of thymocyte differentiation with clinical features and outcome. The 67 boys and 34 girls with T-ALL were 1 month to 18 years old (median, 8 years) with leukocyte counts ranging from 2 to 810 x 10(9)/L (median, 55 x 10(9)/L). Eighteen of these patients were black, and 70 had a mediastinal mass. Twenty-six boys and five girls with a median age of 9 years (range, 1 to 20 years) had T-NHL. Seven of these patients were black, and 24 had a mediastinal mass. The distributions of thymocyte developmental stages (early [CD7+], intermediate [CD1+ and/or CD4+ and/or CD8+], and mature [CD3+]) in cases of T-ALL and T-NHL were significantly different: 34%, 43%, and 23% v 6%, 62%, and 32% (P = .02). A comparison of the patients' clinical features according to the maturational stage of thymocytes failed to disclose significant differences in the majority of characteristics studied. However, patients with mature-stage T-NHL, with or without the addition of subjects with mature-stage T-ALL, were less likely to have a mediastinal mass (P = .02 for both comparisons). Those with intermediate-stage T-cell malignancy (T-ALL and T-NHL combined) were the subgroup most likely to have a mediastinal mass (P = .01). Response to remission induction therapy was significantly worse in the T-ALL subgroup with an early-stage phenotype: a failure rate of 21% v 0% and 6% for the two more differentiated phenotypic subgroups (P = .007). Event-free survival was not affected by thymocyte maturational stage in cases of either T-ALL or T-NHL. Despite evidence of clinical heterogeneity among the maturational stages of T-cell malignancies in children, these developmental subdivisions do not appear to be critical determinants of outcome once remission is achieved. We conclude that such phenotypes need not be included in the stratification plans for clinical trials using common induction treatment. 相似文献
85.
Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele 总被引:1,自引:0,他引:1
Multiple myeloma is a disease characterized by a long, slowly progressive phase and a final, more aggressive one. Little is known about the mechanism of transformation of myeloma cells, although the clinical characteristics of the disease suggest a multi-step process. Recently, a myeloma cell line, NCI-H929, was isolated from a patient with aggressive preterminal disease and found to have a rearranged myc allele. This myeloma cell line has been further characterized in a focus formation assay to determine whether its unusual growth characteristics were associated with a second activated transforming gene. We now report that the NCI-H929 myeloma cell line has an activated rasn allele in addition to a rearranged myc allele. This is the first identification of an activated transforming gene in a multiple myeloma cell line; furthermore, the characterization of two independently activated oncogenes in this B cell malignancy has implications for both the pathogenesis and evolution of the disease. 相似文献
86.
87.
BackgroundBreast cancer is the most common type of cancer in the UK, even though it predominantly affects women. Some research suggests that obesity before menopause can be protective against breast cancer, whereas postmenopausal obesity poses increased risk. Because of a period of latency in the development of cancer, longitudinal cohort studies are essential. The aim of this research was to investigate the association between body-mass index (BMI) and breast cancer incidence.MethodsThe UK Women's Cohort Study was established in the 1990s to investigate patterns between diet and health. 35 000 women were recruited and followed up via cancer incidence and mortality data reports from the National Health Service information centre. Self-reported height and weight were used to calculate BMI. WHO cut-off points were used to define BMI categories. Age-adjusted Cox proportional hazards regression was applied with Stata (version IC12).Findings1445 (4%) of 35 372 women developed breast cancer during a median time to follow-up of 14·9 years (IQR 1·4). Cases prevalent at baseline were excluded. There were significant differences between the observed and expected outcomes by BMI category (p=0·0003, log-rank test), with underweight and normal weight having lower observed than expected incidence. Overweight and obese women had higher observed than expected incidence. Test for trend of survivor functions showed a significant trend of increasing breast cancer incidence with increasing BMI for the whole cohort (p=0·0001) and the postmenopausal subgroup (p=0·0001), but not for premenopausal women. Hazard ratios in an age-adjusted model were significant in postmenopausal women: underweight 1·0 (reference); normal weight 1·6, 95% CI 0·8–3·2; overweight 2·0, 1·0–4·1; obese 2·1, 1·0–4·3.InterpretationWe found a clear association between BMI and breast cancer incidence, especially in postmenopausal women. We did not see an association in premenopausal women. These results are supportive of existing scientific literature and highlight the importance of maintaining a healthy weight in adulthood, especially after the menopause. Health-care professionals should consider referral of overweight and obese women to weight loss services as a protective measure before menopause.FundingThis research was funded as part of an Economic and Social Research Council/Medical Research Council interdisciplinary PhD studentship. 相似文献
88.
Oluwatoyosi B. A. Owoeye Brianna Ghali Kimberley Befus Carlyn Stilling Abigail Hogg John Choi Luz Palacios-Derflingher Kati Pasanen Carolyn A. Emery 《Scandinavian journal of medicine & science in sports》2020,30(12):2466-2476
This study evaluated the incidence and characteristics of all-complaint injuries, including acute and overuse injuries, in female and male youth basketball players. A total of 518 players (16 ± 1.4 years; 38.6% females), from 63 teams, participated in this prospective cohort study. Players were observed through one competitive high school or club basketball season to record exposure and all-complaint injuries, defined as any complaint resulting from participating in basketball-related activities, including but irrespective of the need for medical attention or time loss. Injury incidence rates and rate ratios were derived from Poisson's regression with 99.4% CI (Bonferroni's correction for multiple comparisons). The overall injury incidence rate was 14.4 (99.4% CI: 12.2-17.0) injuries/1000 h; 13.8 (99.4% CI: 11.2-16.8) in females and 14.8 (99.4% CI: 11.7-18.8) in males. While the incidence of injury was similar across injury classifications for female and male players, a potential lower overuse knee injury rate was noted for females vs males [IRR = 0.61 (99.4% CI: 0.34-1.07)]. The most commonly injured body location was the ankle (45%) in females and the knee (51%) in males. Overuse (vs acute) injuries were about 2x more common in the knee while acute (vs overuse) injuries were about 3x more common in the ankle, overall, and for female and male players. Based on an all-complaint injury definition, injury rates in competitive female and male youth basketball players are much higher than previously reported. This study provides an evidence base to inform more tailored interventions to reduce injuries in youth basketball. 相似文献
89.
Theresa Liu Glen T Howell Lucy Turner Kimberley Corace Gary Garber Curtis Cooper 《Journal canadien de gastroenterologie》2014,28(7):381-384
BACKGROUND:
Marijuana smoking is prevalent among hepatitis C virus-infected patients. The literature assessing the influence of marijuana on liver disease progression and hepatitis C virus antiviral treatment outcomes is conflicting.METHODS:
The authors evaluated hepatitis C virus RNA-positive patients followed at The Ottawa Hospital Viral Hepatitis Clinic (Ottawa, Ontario) from 2000 to 2009. Using The Ottawa Hospital Viral Hepatitis Clinic database and charts, information regarding demographics, HIV coinfection, alcohol use, liver biopsy results, treatment outcomes and self-reported marijuana use was extracted. Biopsy characteristics and hepatitis C virus antiviral treatment outcomes were assessed for association with categorized marijuana use by adjusted logistic regression; covariates were specified according to clinical relevance a priori.RESULTS:
Information regarding marijuana use was available for 550 patients, 159 (28.9%) of whom were using marijuana at the time of first assessment. Biopsy fibrosis stage and marijuana use data were available for 377 of these 550 (F0-2=72.3%). Overall, marijuana use did not predict fibrosis stage, inflammation grade or steatosis. Sustained virological response and marijuana use data were available for 359 of the 550 cohort participants; a total of 211 (58.8%) achieved a sustained virological response. Marijuana use was not associated with premature interruption of therapy for side effects, the likelihood of completing a full course of therapy or sustained virological response.CONCLUSION:
Marijuana use did not influence biopsy histology or alter key hard outcomes of hepatitis C virus antiviral therapy. 相似文献90.
James D. Livingston Michelle Cianfrone Kimberley Korf-Uzan Connie Coniglio 《Social psychiatry and psychiatric epidemiology》2014,49(6):985-990